-
1دورية أكاديمية
المؤلفون: Ahmad Basha, Mohamed Izham Mohamed Ibrahim, Anas Hamad, Prem Chandra, Nabil E Omar, Mohamed Abdul Jaber Abdullah, Mahmood B Aldapt, Radwa M Hussein, Ahmed Mahfouz, Ahmad A Adel, Hawraa M Shwaylia, Yaslem Ekeibed, Rami AbuMousa, Mohamed A Yassin
المصدر: PLoS ONE, Vol 16, Iss 8, p e0255104 (2021)
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1932-6203
-
2دورية أكاديمية
المؤلفون: Safae Abuyousef, Shaikha Alnaimi, Nabil E. Omar, Reem Elajez, Eman Elmekaty, Eiman Abdelfattah-Arafa, Raja Barazi, Rola Ghasoub, Ala Rahhal, Fatima Hamou, Maha Al-Amri, Ahmed Karawia, Fatima Ajaj, Raja Alkhawaja, Ahmed Kardousha, Ahmed Awaisu, Adel Abou-Ali, Mohamad Khatib, Mohammed Aboukamar, Moza Al-Hail
المصدر: Frontiers in Public Health, Vol 12 (2024)
مصطلحات موضوعية: COVID-19, predictors, risk factors, intensive care unit, mortality, critically ill patients, Public aspects of medicine, RA1-1270
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Ahmed Abdalhadi, Nabil E. Omar, Samah Kohla, Hassan Aakel, Yeslem Ekeibed, Reyad Mohsen
المصدر: Frontiers in Oncology, Vol 14 (2024)
مصطلحات موضوعية: EGFR, TKI, SCLC, AA, lung adecarcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: Fateen Ata, Maria Benkhadra, Rola Ghasoub, Liam J. Fernyhough, Nabil E. Omar, Abdulqadir J. Nashwan, Mahmood B. Aldapt, Kamran Mushtaq, Nancy A. Kassem, Mohamed A. Yassin
المصدر: Frontiers in Oncology, Vol 13 (2023)
مصطلحات موضوعية: Tyrosine Kinase Inhibitors, TKI, pediatric chronic myeloid leukemia, CML, Imatinib, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
5دورية أكاديمية
المؤلفون: Mohammad Altermanini, Khaled Ali, Wisam Alwassiti, Suliman Almohtasib, Nabil E. Omar, Abdulaziz Zafar
المصدر: Case Reports in Oncology, Vol 16, Iss 1, Pp 728-733 (2023)
مصطلحات موضوعية: pembrolizumab, rhabdomyolysis, renal cell carcinoma, oncology, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
6دورية أكاديمية
المؤلفون: Phool Iqbal, Fateen Ata, Hassan Chaudhry, Bassam Muthanna, Hafiz Waqas Younas, Syed Ata ul Munamm, Rohit Sharma, Kahtan Fadah, Shereen Elazzazy, Anas Hamad, Osama Said Abu Tabar, Nabil E. Omar
المصدر: Health Science Reports, Vol 6, Iss 4, Pp n/a-n/a (2023)
مصطلحات موضوعية: COVID‐19 complications, long COVID, Meta‐analysis, Post COVID‐19, SARS‐CoV‐2 sequelae, Medicine
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2398-8835
-
7دورية أكاديمية
المؤلفون: Ahmed Abdalhadi, Mouhammad J Alawad, Nabil E. Omar, Muhammed Hajmusa, Mohammed Gaber, Alaaeldin Shablak
المصدر: Current Problems in Cancer: Case Reports, Vol 9, Iss , Pp 100214- (2023)
مصطلحات موضوعية: Tracheoesophageal fistula, Gastroesophageal junction tumor, Ramucirumab, Anti-angiogenic, FOLFOX, GEJ, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
8دورية أكاديمية
المؤلفون: Farah Rashid, Nabil E. Omar, Hassan Aaekl, Ussama Al Homsi, Alaaeldin Shablak
المصدر: Clinical Case Reports, Vol 10, Iss 10, Pp n/a-n/a (2022)
مصطلحات موضوعية: cerebrovascular accident, cisplatin, cisplatin induced stroke, small cell lung cancer, Medicine, Medicine (General), R5-920
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2050-0904
-
9دورية أكاديمية
المؤلفون: Rana Mekkawi BSc (Pharm), PharmD, Bassant A. Elkattan BSc (Pharm), Alaaeldin Shablak MD, MSc, MRCP, Mohammad Bakr MB BCh, MSc, MD, Mohamed A. Yassin MBBS, MSc, Nabil E. Omar BSc (Pharm), PharmD, BCOP, PhD(c)
المصدر: Cancer Control, Vol 29 (2022)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1073-2748
-
10دورية أكاديمية
المؤلفون: Nabil E. Omar, Kareem A. El-Fass, Abdelrahman I. Abushouk, Noha Elbaghdady, Abd Elmonem M. Barakat, Ahmed E. Noreldin, Dina Johar, Mohamed Yassin, Anas Hamad, Shereen Elazzazy, Said Dermime
المصدر: Frontiers in Immunology, Vol 11 (2020)
مصطلحات موضوعية: immune checkpoint inhibitors, immune-related adverse events, ipilimumab, pembrolizumab, nivolumab, atezolizumab, Immunologic diseases. Allergy, RC581-607
وصف الملف: electronic resource